{"created":"2024-12-02T04:08:04.117745+00:00","id":2001954,"links":{},"metadata":{"_buckets":{"deposit":"db7628db-1211-4707-8906-00fcfa8c6701"},"_deposit":{"created_by":8,"id":"2001954","owners":[8],"pid":{"revision_id":0,"type":"depid","value":"2001954"},"status":"published"},"_oai":{"id":"oai:fmu.repo.nii.ac.jp:02001954","sets":["1732778801467:1732778962699:1733108131262"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Immunotherapy for esophageal squamous cell carcinoma: a review","subitem_title_language":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Mimura, Kosaku","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Yamada, Leo","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ujiie, Daisuke","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Hayase, Suguru","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Tada, Takeshi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Hanayama, Hiroyuki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Aung Kyi Thar Min","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Shibata, Masahiko","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Momma, Tomoyuki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Saze, Zenichiro","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ohki, Shinji","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kono, Koji","creatorNameLang":"en"}]}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"© 2018 The Fukushima Society of Medical Science","subitem_rights_language":"en"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_subject":"esophageal squamous cell carcinoma","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"immunotherapy","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"cancer vaccine","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"immune checkpoint inhibitors","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"Cancer vaccines and immune checkpoint inhibitors (ICI) have recently been employed as immunotherapies for esophageal squamous cell carcinoma (ESCC). Cancer vaccines for ESCC have yielded several promising results from investigator-initiated phase I and II clinical trials. Furthermore, a Randomized Controlled Trial as an adjuvant setting after curative surgery is in progress in Japan. On the other hand, ICI, anti-CTLA-4 mAb and anti-PD-1 mAb, have demonstrated tumor shrinkage and improved overall survival in patients with multiple cancer types. For ESCC, several clinical trials using anti-PD-1/anti-PD-L1 mAb are underway with several recent promising results. In this review, cancer vaccines and ICI are discussed as novel therapeutic strategies for ESCC.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_publisher":"The Fukushima Society of Medical Science","subitem_publisher_language":"en"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617186920753":{"attribute_name":"Source Identifier","attribute_value_mlt":[{"subitem_source_identifier":"0016-2590","subitem_source_identifier_type":"PISSN"},{"subitem_source_identifier":"2185-4610","subitem_source_identifier_type":"EISSN"},{"subitem_source_identifier":"AA0065246X","subitem_source_identifier_type":"NCID"}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"2","bibliographicPageEnd":"53","bibliographicPageStart":"46","bibliographicVolumeNumber":"64","bibliographic_titles":[{"bibliographic_title":"Fukushima Journal of Medical Science","bibliographic_titleLang":"en"}]}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.5387/fms.2018-09","subitem_relation_type_select":"DOI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"30058598","subitem_relation_type_select":"PMID"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"2020139711","subitem_relation_type_select":"ICHUSHI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2018-09-14"}],"displaytype":"detail","filename":"FksmJMedSci_64_p46.pdf","filesize":[{"value":"1.4 MB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"url":"https://fmu.repo.nii.ac.jp/record/2001954/files/FksmJMedSci_64_p46.pdf"},"version_id":"44842613-89b5-4165-8e2b-230c813f0812"}]},"item_title":"Immunotherapy for esophageal squamous cell carcinoma: a review","item_type_id":"40002","owner":"8","path":["1733108131262"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2018-09-14"},"publish_date":"2018-09-14","publish_status":"0","recid":"2001954","relation_version_is_last":true,"title":["Immunotherapy for esophageal squamous cell carcinoma: a review"],"weko_creator_id":"8","weko_shared_id":-1},"updated":"2024-12-02T04:12:15.709787+00:00"}